BIOMAT Database Logo BIOMAT Database Logo

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients. 1995

M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Department of Obstetrics and Gynaecology, Free University Hospital, Amsterdam, The Netherlands.

Circulating immune complexes (CICs) containing polymorphic epithelial mucin (PEM/MUC-1) were found in sera of 24.5% of 151 primary breast carcinoma patients and 18-21.4% of patients with advanced ovarian (n = 56) and breast carcinomas (n = 61), 37% of patients with benign breast tumours, but in only 2.1% of 96 healthy individuals. The incorporation of PEM into CICs affects the detection of circulating PEM in commercial immunoassays such as the CA 15-3 assay, as suggested by a negative correlation between levels of PEM-containing immune complexes (PEM-CICs) and CA 15-3 values, and confirmed by isolation of PEM from CA 15-3-negative sera containing high levels of PEM-CICs. The amounts of PEM masked by human antibodies correspond to significant values of the CA 15-3 assay when monitoring patients for carcinoma. Most antibodies in PEM-CICs were of IgG class, suggesting their specific nature to the PEM epitopes.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune

Related Publications

M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
MUC-1 epithelial tumor mucin-based immunity and cancer vaccines.
June 1995, Immunological reviews,
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Immunoglobulins containing circulating immune complexes in hypercholesterolaemic patients.
April 1986, Atherosclerosis,
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Circulating immune complexes in patients with nasopharyngeal carcinoma.
March 1990, The Laryngoscope,
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Human B-cell immune response to the polymorphic epithelial mucin.
June 1993, Cancer research,
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Expression of mucin (MUC) genes in mucoepidermoid carcinoma.
January 2011, The Laryngoscope,
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z).
July 1997, International journal of cancer,
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
IgA-containing circulating immune complexes in patients with igA nephropathy.
January 1983, The American journal of medicine,
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Circulating DNA-containing immune complexes in SLE.
April 1983, Journal of immunology (Baltimore, Md. : 1950),
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Spatial and temporal expression of an epithelial mucin, Muc-1, during mouse development.
June 1992, Development (Cambridge, England),
M M Gourevitch, and S von Mensdorff-Pouilly, and S V Litvinov, and P Kenemans, and G J van Kamp, and A A Verstraeten, and J Hilgers
Recombinant epithelial cell mucin (MUC-1) expressed in baculovirus resembles antigenically tumor associated mucin, target for cancer immunotherapy.
January 1995, Biomedical peptides, proteins & nucleic acids : structure, synthesis & biological activity,
Copied contents to your clipboard!